Home
>
National Drug Code (NDC)
>
Bicalutamide
Bicalutamide - 16729-023-01 - (Bicalutamide)
Drug Information of Bicalutamide
| Product NDC: | 16729-023 |
| Proprietary Name: | Bicalutamide |
| Non Proprietary Name: | Bicalutamide |
| Active Ingredient(s): | 50 mg/1 & nbsp; Bicalutamide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Bicalutamide
| Product NDC: | 16729-023 |
| Labeler Name: | Accord Healthcare Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078917 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090706 |
Package Information of Bicalutamide
| Package NDC: | 16729-023-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (16729-023-01) |
NDC Information of Bicalutamide
| NDC Code | 16729-023-01 |
| Proprietary Name | Bicalutamide |
| Package Description | 100 TABLET in 1 BOTTLE (16729-023-01) |
| Product NDC | 16729-023 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Bicalutamide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20090706 |
| Marketing Category Name | ANDA |
| Labeler Name | Accord Healthcare Inc |
| Substance Name | BICALUTAMIDE |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Androgen Receptor Antagonists [MoA],Androgen Receptor Inhibitor [EPC] |
